30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Tenaya Therapeutics Inc (TNYA)

Track

Over the last 90 days, Tenaya Therapeutics Inc. has seen net insider selling totaling $6,344.35, with three executives selling shares. The stock price has decreased by 2.8% in the same period. No insider buying activity was recorded. The company's next earnings report is scheduled for August 12, 2026.
Stock chart
Ticker: TNYA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Higa Tomohiro
SVP, Finance
1 sale — total 1,178 USD
Sale 18 May 2026
Value US$3,405,820.75 | Price 153.17 | Shares 84,464
Sale 18 May 2026
Value US$4,538,409.75 | Price 205.35 | Shares 54,722
Sale 18 May 2026
Value US$2,689.63 | Price 0.79 | Shares 3,390
Sale 25 Feb 2026
Value US$1,047,495.31 | Price 0.56 | Shares 1,862,545
Sale 25 Feb 2026
Value US$927,555.63 | Price 0.56 | Shares 1,649,281
Proposed sale 25 Feb 2026
Value US$565,442.00 | Price 0.60 | Shares 939,273
Proposed sale 25 Feb 2026
Value US$596,552.86 | Price 0.56 | Shares 1,060,727
Sale 24 Feb 2026
Value US$214,870.14 | Price 0.62 | Shares 349,212
Sale 24 Feb 2026
Value US$190,267.99 | Price 0.62 | Shares 309,228
Sale 23 Feb 2026
Value US$96,920.19 | Price 0.60 | Shares 162,291
Sale 23 Feb 2026
Value US$85,823.01 | Price 0.60 | Shares 143,709
Sale 20 Feb 2026
Value US$170,800.16 | Price 0.61 | Shares 277,769
Sale 20 Feb 2026
Value US$151,243.88 | Price 0.61 | Shares 245,965
Proposed sale 20 Feb 2026
Value US$872,537.96 | Price 0.62 | Shares 1,408,910
Proposed sale 20 Feb 2026
Value US$985,362.04 | Price 0.62 | Shares 1,591,090
Sale 17 Feb 2026
Value US$1,300.35 | Price 0.64 | Shares 2,022
Sale 17 Feb 2026
Value US$537.88 | Price 0.64 | Shares 836
Sale 17 Feb 2026
Value US$393.12 | Price 0.64 | Shares 611
Sale 17 Feb 2026
Value US$1,206.46 | Price 0.64 | Shares 1,876
Sale 17 Feb 2026
Value US$1,056.13 | Price 0.64 | Shares 1,642
Planned sale 17 Feb 2026
Value US$1,056.13 | Price 0.64 | Shares 1,642
Sale 17 Feb 2026
Value US$3,235.58 | Price 0.64 | Shares 5,032
Sale 17 Feb 2026
Value US$2,558.89 | Price 0.64 | Shares 3,979
Sale 17 Feb 2026
Value US$3,762.19 | Price 0.64 | Shares 5,851
Proposed sale 17 Feb 2026
Value US$9,556.66 | Price 0.64 | Shares 14,862
Proposed sale 17 Feb 2026
Value US$3,318.72 | Price 0.64 | Shares 5,160
Sale 11 Feb 2026
Value US$1,464,712.61 | Price 0.68 | Shares 2,151,458
Sale 11 Feb 2026
Value US$1,297,002.29 | Price 0.68 | Shares 1,905,115
Proposed sale 11 Feb 2026
Value US$446,989.00 | Price 0.68 | Shares 657,627
Proposed sale 11 Feb 2026
Value US$504,788.00 | Price 0.68 | Shares 742,663
Sale 10 Feb 2026
Value US$148,770.95 | Price 0.82 | Shares 182,295
Sale 10 Feb 2026
Value US$131,736.49 | Price 0.82 | Shares 161,422
Proposed sale 10 Feb 2026
Value US$1,256,960.80 | Price 0.79 | Shares 1,591,090
Proposed sale 10 Feb 2026
Value US$1,113,038.00 | Price 0.79 | Shares 1,408,910
Sale 17 Nov 2025
Value US$4,157.58 | Price 1.33 | Shares 3,126
Sale 17 Nov 2025
Value US$1,818.11 | Price 1.33 | Shares 1,367
Sale 17 Nov 2025
Value US$3,826.41 | Price 1.33 | Shares 2,877
Proposed sale 18 Aug 2025
Value US$6,331.41 | Price 1.25 | Shares 5,053
Proposed sale 18 Aug 2025
Value US$18,209.85 | Price 1.25 | Shares 14,533
Sale 18 Aug 2025
Value US$2,157.67 | Price 1.25 | Shares 1,722
Sale 18 Aug 2025
Value US$898.40 | Price 1.25 | Shares 717
Sale 18 Aug 2025
Value US$655.32 | Price 1.25 | Shares 523
Sale 18 Aug 2025
Value US$2,301.76 | Price 1.25 | Shares 1,837
Sale 18 Aug 2025
Value US$2,014.82 | Price 1.25 | Shares 1,608
Planned sale 18 Aug 2025
Value US$2,014.82 | Price 1.25 | Shares 1,608
Sale 18 Aug 2025
Value US$6,164.76 | Price 1.25 | Shares 4,920
Sale 18 Aug 2025
Value US$4,877.93 | Price 1.25 | Shares 3,893
Sale 18 Aug 2025
Value US$7,167.16 | Price 1.25 | Shares 5,720
Sale 16 May 2025
Value US$1,300.21 | Price 0.44 | Shares 2,937
Sale 16 May 2025
Value US$1,411.77 | Price 0.44 | Shares 3,189
Sale 16 May 2025
Value US$615.35 | Price 0.44 | Shares 1,390
Proposed sale 10 Mar 2025
Value US$3,983.08 | Price 0.54 | Shares 7,398
Proposed sale 10 Mar 2025
Value US$5,244.55 | Price 0.54 | Shares 9,741
Sale 10 Mar 2025
Value US$454.95 | Price 0.54 | Shares 845
Sale 10 Mar 2025
Value US$333.81 | Price 0.54 | Shares 620
Sale 10 Mar 2025
Value US$547.55 | Price 0.54 | Shares 1,017
Sale 10 Mar 2025
Value US$2,125.06 | Price 0.54 | Shares 3,947
Sale 10 Mar 2025
Value US$3,119.49 | Price 0.54 | Shares 5,794
Sale 10 Mar 2025
Value US$860.36 | Price 0.54 | Shares 1,598
Sale 10 Mar 2025
Value US$2,192.90 | Price 0.54 | Shares 4,073
Planned sale 10 Mar 2025
Value US$929.82 | Price 0.54 | Shares 1,727
Buy 5 Mar 2025
Value US$24,999,998.80 | Price 0.70 | Shares 35,714,284
Buy 5 Mar 2025
Value US$24,999,998.80 | Price 0.70 | Shares 35,714,284
Sale 18 Nov 2024
Value US$4,786.96 | Price 2.12 | Shares 2,258
Sale 16 Aug 2024
Value US$2,335.86 | Price 2.89 | Shares 807
Sale 16 Aug 2024
Value US$1,893.00 | Price 2.89 | Shares 654
Sale 16 Aug 2024
Value US$2,610.84 | Price 2.89 | Shares 902
Proposed sale 16 Aug 2024
Value US$21,466.92 | Price 2.89 | Shares 7,428
Proposed sale 16 Aug 2024
Value US$28,171.72 | Price 2.89 | Shares 9,748
Planned sale 16 Aug 2024
Value US$4,703.56 | Price 2.89 | Shares 1,625
Planned sale 16 Aug 2024
Value US$16,796.78 | Price 2.89 | Shares 5,803
Sale 16 Aug 2024
Value US$11,421.70 | Price 2.89 | Shares 3,946
Sale 16 Aug 2024
Value US$16,793.89 | Price 2.89 | Shares 5,802
Planned sale 5 Mar 2024
Value US$23,100.99 | Price 7.00 | Shares 3,300
Proposed sale 5 Mar 2024
Value US$132,200.00 | Price 6.61 | Shares 20,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-19 2026-05-18 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
84,464 +26.3%
153.17
US$3,405,821 		84,464 +26.3% 153.17 US$3,405,821
2026-05-19 2026-05-18 S Sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
54,722 +11.2%
205.35
US$4,538,410 		54,722 +11.2% 205.35 US$4,538,410
2026-05-19 2026-05-18 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
94,110 +30.7%
492.67
US$3,684,561 		94,110 +30.7% 492.67 US$3,684,561
2026-02-26 2026-02-25 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
1,862,545 -100.0%
0.56
US$1,047,495 		1,862,545 -100.0% 0.56 US$1,047,495
2026-02-26 2026-02-25 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
1,649,281 -100.0%
0.56
US$927,556 		1,649,281 -100.0% 0.56 US$927,556
2026-02-25 2026-02-25 PrS Proposed sale
COLUMN GROUP III, LP

10% Stockholder

Large shareholder
939,273
0.60
US$565,442 		939,273 0.60 US$565,442
2026-02-25 2026-02-25 PrS Proposed sale
COLUMN GROUP III-A, LP

10% Stockholder

Large shareholder
1,060,727
0.56
US$596,553 		1,060,727 0.56 US$596,553
2026-02-26 2026-02-24 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
349,212 -15.8%
0.62
US$214,870 		349,212 -15.8% 0.62 US$214,870
2026-02-26 2026-02-24 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
309,228 -15.8%
0.62
US$190,268 		309,228 -15.8% 0.62 US$190,268
2026-02-24 2026-02-23 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
162,291 -6.8%
0.60
US$96,920 		162,291 -6.8% 0.60 US$96,920
2026-02-24 2026-02-23 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
143,709 -6.8%
0.60
US$85,823 		143,709 -6.8% 0.60 US$85,823
2026-02-24 2026-02-20 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
277,769 -10.5%
0.61
US$170,800 		277,769 -10.5% 0.61 US$170,800
2026-02-24 2026-02-20 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
245,965 -10.5%
0.61
US$151,244 		245,965 -10.5% 0.61 US$151,244
2026-02-20 2026-02-20 PrS Proposed sale
COLUMN GROUP III, LP

10% Stockholder

Large shareholder
1,408,910
0.62
US$872,538 		1,408,910 0.62 US$872,538
2026-02-20 2026-02-20 PrS Proposed sale
COLUMN GROUP III-A, LP

10% Stockholder

Large shareholder
1,591,090
0.62
US$985,362 		1,591,090 0.62 US$985,362
2026-02-17 2026-02-17 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
2,022 -1.7%
0.64
US$1,300 		2,022 -1.7% 0.64 US$1,300
2026-02-17 2026-02-17 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
836 -0.7%
0.64
US$538 		836 -0.7% 0.64 US$538
2026-02-17 2026-02-17 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
611 -0.5%
0.64
US$393 		611 -0.5% 0.64 US$393
2026-02-17 2026-02-17 S Sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
1,876 -0.9%
0.64
US$1,206 		1,876 -0.9% 0.64 US$1,206
2026-02-17 2026-02-17 S Sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
1,642 -0.7%
0.64
US$1,056 		1,642 -0.7% 0.64 US$1,056
2026-02-17 2026-02-17 PlS Planned sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
1,642 -0.7%
0.64
US$1,056 		1,642 -0.7% 0.64 US$1,056
2026-02-17 2026-02-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,032 -1.1%
0.64
US$3,236 		5,032 -1.1% 0.64 US$3,236
2026-02-17 2026-02-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,979 -0.9%
0.64
US$2,559 		3,979 -0.9% 0.64 US$2,559
2026-02-17 2026-02-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,851 -1.3%
0.64
US$3,762 		5,851 -1.3% 0.64 US$3,762
2026-02-17 2026-02-17 PrS Proposed sale
4.1
Faraz Ali

Officer; Director

Executive Director
14,862
0.64
US$9,557 		14,862 0.64 US$9,557
2026-02-17 2026-02-17 PrS Proposed sale
3.0
Whittemore Tingley

Officer

Officer
5,160
0.64
US$3,319 		5,160 0.64 US$3,319
2026-02-12 2026-02-11 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
2,151,458 -44.8%
0.68
US$1,464,713 		2,151,458 -44.8% 0.68 US$1,464,713
2026-02-12 2026-02-11 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
1,905,115 -44.8%
0.68
US$1,297,002 		1,905,115 -44.8% 0.68 US$1,297,002
2026-02-11 2026-02-11 PrS Proposed sale
COLUMN GROUP III, LP

10% Stockholder

Large shareholder
657,627
0.68
US$446,989 		657,627 0.68 US$446,989
2026-02-11 2026-02-11 PrS Proposed sale
COLUMN GROUP III-A, LP

10% Stockholder

Large shareholder
742,663
0.68
US$504,788 		742,663 0.68 US$504,788
2026-02-12 2026-02-10 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
182,295 -3.7%
0.82
US$148,771 		182,295 -3.7% 0.82 US$148,771
2026-02-12 2026-02-10 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
161,422 -3.7%
0.82
US$131,736 		161,422 -3.7% 0.82 US$131,736
2026-02-10 2026-02-10 PrS Proposed sale
COLUMN GROUP III-A, LP

10% Stockholder

Large shareholder
1,591,090
0.79
US$1,256,961 		1,591,090 0.79 US$1,256,961
2026-02-10 2026-02-10 PrS Proposed sale
COLUMN GROUP III, LP

10% Stockholder

Large shareholder
1,408,910
0.79
US$1,113,038 		1,408,910 0.79 US$1,113,038
2025-11-17 2025-11-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,126 -1.0%
1.33
US$4,158 		3,126 -1.0% 1.33 US$4,158
2025-11-17 2025-11-17 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
1,367 -1.4%
1.33
US$1,818 		1,367 -1.4% 1.33 US$1,818
2025-11-17 2025-11-17 S Sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
2,877 -1.7%
1.33
US$3,826 		2,877 -1.7% 1.33 US$3,826
2025-08-18 2025-08-18 PrS Proposed sale
3.0
Whittemore Tingley

Officer

Officer
5,053
1.25
US$6,331 		5,053 1.25 US$6,331
2025-08-18 2025-08-18 PrS Proposed sale
4.1
Faraz Ali

Officer; Director

Executive Director
14,533
1.25
US$18,210 		14,533 1.25 US$18,210
2025-08-18 2025-08-18 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
1,722 -1.8%
1.25
US$2,158 		1,722 -1.8% 1.25 US$2,158
2025-08-18 2025-08-18 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
717 -0.7%
1.25
US$898 		717 -0.7% 1.25 US$898
2025-08-18 2025-08-18 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
523 -0.5%
1.25
US$655 		523 -0.5% 1.25 US$655
2025-08-18 2025-08-18 S Sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
1,837 -1.1%
1.25
US$2,302 		1,837 -1.1% 1.25 US$2,302
2025-08-18 2025-08-18 S Sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
1,608 -0.9%
1.25
US$2,015 		1,608 -0.9% 1.25 US$2,015
2025-08-18 2025-08-18 PlS Planned sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
1,608 -0.9%
1.25
US$2,015 		1,608 -0.9% 1.25 US$2,015
2025-08-18 2025-08-18 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
4,920 -1.6%
1.25
US$6,165 		4,920 -1.6% 1.25 US$6,165
2025-08-18 2025-08-18 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,893 -1.2%
1.25
US$4,878 		3,893 -1.2% 1.25 US$4,878
2025-08-18 2025-08-18 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,720 -1.8%
1.25
US$7,167 		5,720 -1.8% 1.25 US$7,167
2025-05-16 2025-05-16 S Sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
2,937 -1.7%
0.44
US$1,300 		2,937 -1.7% 0.44 US$1,300
2025-05-16 2025-05-16 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,189 -1.0%
0.44
US$1,412 		3,189 -1.0% 0.44 US$1,412
2025-05-16 2025-05-16 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
1,390 -1.4%
0.44
US$615 		1,390 -1.4% 0.44 US$615
2025-03-10 2025-03-10 PrS Proposed sale
3.0
Whittemore Tingley

Officer

Officer
7,398
0.54
US$3,983 		7,398 0.54 US$3,983
2025-03-10 2025-03-10 PrS Proposed sale
4.1
Faraz Ali

Officer; Director

Executive Director
9,741
0.54
US$5,245 		9,741 0.54 US$5,245
2025-03-10 2025-03-10 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
845 -0.8%
0.54
US$455 		845 -0.8% 0.54 US$455
2025-03-10 2025-03-10 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
620 -0.6%
0.54
US$334 		620 -0.6% 0.54 US$334
2025-03-10 2025-03-10 S Sale
3.0
Higa Tomohiro

SVP, Finance

Officer
1,017 -1.0%
0.54
US$548 		1,017 -1.0% 0.54 US$548
2025-03-10 2025-03-10 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,947 -1.2%
0.54
US$2,125 		3,947 -1.2% 0.54 US$2,125
2025-03-10 2025-03-10 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,794 -1.8%
0.54
US$3,119 		5,794 -1.8% 0.54 US$3,119
2025-03-10 2025-03-10 S Sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
1,598 -0.9%
0.54
US$860 		1,598 -0.9% 0.54 US$860
2025-03-10 2025-03-10 S Sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
4,073 -2.3%
0.54
US$2,193 		4,073 -2.3% 0.54 US$2,193
2025-03-10 2025-03-10 PlS Planned sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
1,727 -0.9%
0.54
US$930 		1,727 -0.9% 0.54 US$930
2025-03-07 2025-03-05 B Purchase
2.3
COLUMN GROUP III GP, LP
Large shareholder
35,714,284 +262.6%
0.70
US$24,999,999 		35,714,284 +262.6% 0.70 US$24,999,999
2025-03-07 2025-03-05 B Purchase
3.8
GOEDDEL DAVID V
Non-Executive Director Large shareholder
35,714,284 +262.6%
0.70
US$24,999,999 		35,714,284 +262.6% 0.70 US$24,999,999
2024-11-18 2024-11-18 S Sale
3.7
Saito Chihiro

SVP, Accounting and Fin. Ops.

Officer
2,258 -3.6%
2.12
US$4,787 		2,258 -3.6% 2.12 US$4,787
2024-08-19 2024-08-16 S Sale
3.7
Saito Chihiro

SVP, Accounting and Fin. Ops.

Officer
807 -1.3%
2.89
US$2,336 		807 -1.3% 2.89 US$2,336
2024-08-19 2024-08-16 S Sale
3.7
Saito Chihiro

SVP, Accounting and Fin. Ops.

Officer
654 -1.0%
2.89
US$1,893 		654 -1.0% 2.89 US$1,893
2024-08-19 2024-08-16 S Sale
3.7
Saito Chihiro

SVP, Accounting and Fin. Ops.

Officer
902 -1.4%
2.89
US$2,611 		902 -1.4% 2.89 US$2,611
2024-08-16 2024-08-16 PrS Proposed sale
3.0
Whittemore Tingley

Officer

Officer
7,428
2.89
US$21,467 		7,428 2.89 US$21,467
2024-08-16 2024-08-16 PrS Proposed sale
4.1
Faraz Ali

Officer; Director

Executive Director
9,748
2.89
US$28,172 		9,748 2.89 US$28,172
2024-08-16 2024-08-16 PlS Planned sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
1,625 -1.5%
2.89
US$4,704 		1,625 -1.5% 2.89 US$4,704
2024-08-16 2024-08-16 PlS Planned sale
3.0
Tingley Whittemore

Chief Medical Officer

Officer
5,803 -5.1%
2.89
US$16,797 		5,803 -5.1% 2.89 US$16,797
2024-08-16 2024-08-16 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,946 -2.1%
2.89
US$11,422 		3,946 -2.1% 2.89 US$11,422
2024-08-16 2024-08-16 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,802 -2.9%
2.89
US$16,794 		5,802 -2.9% 2.89 US$16,794
2024-03-06 2024-03-05 PlS Planned sale
3.7
Hoey Timothy

Chief Scientific Officer

Officer
3,300 -1.3%
7.00
US$23,101 		3,300 -1.3% 7.00 US$23,101
2024-03-05 2024-03-05 PrS Proposed sale
3.7
TIMOTHY HOEY

Officer

Officer
20,000
6.61
US$132,200 		20,000 6.61 US$132,200
Explore more

More insider trading research around Tenaya Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America